21-45480419-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001379500.1(COL18A1):c.1399-48C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0761 in 1,613,576 control chromosomes in the GnomAD database, including 6,177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 1293 hom., cov: 33)
Exomes 𝑓: 0.073 ( 4884 hom. )
Consequence
COL18A1
NM_001379500.1 intron
NM_001379500.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.00
Publications
6 publications found
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL18A1 Gene-Disease associations (from GenCC):
- Knobloch syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Knobloch syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet
- hereditary glaucoma, primary closed-angleInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 21-45480419-C-G is Benign according to our data. Variant chr21-45480419-C-G is described in ClinVar as Benign. ClinVar VariationId is 261891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL18A1 | NM_001379500.1 | c.1399-48C>G | intron_variant | Intron 11 of 41 | ENST00000651438.1 | NP_001366429.1 | ||
| COL18A1 | NM_130444.3 | c.2644-48C>G | intron_variant | Intron 10 of 40 | NP_569711.2 | |||
| COL18A1 | NM_030582.4 | c.1939-48C>G | intron_variant | Intron 10 of 40 | NP_085059.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL18A1 | ENST00000651438.1 | c.1399-48C>G | intron_variant | Intron 11 of 41 | NM_001379500.1 | ENSP00000498485.1 | ||||
| COL18A1 | ENST00000355480.10 | c.1939-48C>G | intron_variant | Intron 10 of 40 | 1 | ENSP00000347665.5 | ||||
| COL18A1 | ENST00000359759.8 | c.2644-48C>G | intron_variant | Intron 10 of 40 | 5 | ENSP00000352798.4 |
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16543AN: 152068Hom.: 1291 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
16543
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0785 AC: 19499AN: 248366 AF XY: 0.0788 show subpopulations
GnomAD2 exomes
AF:
AC:
19499
AN:
248366
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0727 AC: 106231AN: 1461390Hom.: 4884 Cov.: 34 AF XY: 0.0737 AC XY: 53598AN XY: 726990 show subpopulations
GnomAD4 exome
AF:
AC:
106231
AN:
1461390
Hom.:
Cov.:
34
AF XY:
AC XY:
53598
AN XY:
726990
show subpopulations
African (AFR)
AF:
AC:
7751
AN:
33478
American (AMR)
AF:
AC:
2496
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
1324
AN:
26130
East Asian (EAS)
AF:
AC:
5541
AN:
39698
South Asian (SAS)
AF:
AC:
10556
AN:
86254
European-Finnish (FIN)
AF:
AC:
1180
AN:
53042
Middle Eastern (MID)
AF:
AC:
554
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
71787
AN:
1111922
Other (OTH)
AF:
AC:
5042
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
6090
12181
18271
24362
30452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2842
5684
8526
11368
14210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.109 AC: 16556AN: 152186Hom.: 1293 Cov.: 33 AF XY: 0.106 AC XY: 7851AN XY: 74384 show subpopulations
GnomAD4 genome
AF:
AC:
16556
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
7851
AN XY:
74384
show subpopulations
African (AFR)
AF:
AC:
9106
AN:
41480
American (AMR)
AF:
AC:
1153
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
185
AN:
3472
East Asian (EAS)
AF:
AC:
527
AN:
5164
South Asian (SAS)
AF:
AC:
656
AN:
4810
European-Finnish (FIN)
AF:
AC:
196
AN:
10626
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4482
AN:
68012
Other (OTH)
AF:
AC:
199
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
718
1436
2153
2871
3589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
403
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.